News
07-01-2010, 06:00 AM
AstraZeneca today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300.
More... (http://www.news-medical.net/news/20100701/AstraZeneca-announces-new-support-program-for-patients-on-ARIMIDEX.aspx)
More... (http://www.news-medical.net/news/20100701/AstraZeneca-announces-new-support-program-for-patients-on-ARIMIDEX.aspx)